Global Influenza Diagnostic Market, Global Influenza Diagnostic Market Report, Global Influenza Diagnostic Market Trends, Global Influenza Diagnostic Market Size

Global Influenza Diagnostic Market Projected to Expand at 8% CAGR by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Influenza Diagnostic Market Expected To Become By 2029 Compared With Its 2025 Level?

The influenza diagnostic market has experienced consistent expansion over recent years. It is projected to grow from $2.73 billion in 2024 to $2.87 billion in 2025, at a compound annual growth rate (CAGR) of 4.9%. This past growth can be attributed to various factors including the expansion of e-commerce, insufficient labor, advancements in automation and productivity, enhanced supply chain optimization, rising expenses for labor, and governmental backing for automation and robotics.

The influenza diagnostic market is projected to demonstrate strong growth over the next few years, expanding to $3.9 billion by 2029, at a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is driven by factors such as customization and scalability, environmental and sustainability objectives, the need to enhance operational efficiency, and the requirement to satisfy the demands of modern supply chain dynamics. Significant trends expected during this forecast period include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, AI-driven decision making, collaborative robots, and continuous advancements in robotic technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Influenza Diagnostic Industry?

The expansion of the influenza diagnostic market is expected to be significantly propelled by rapid diagnostic tests. Diagnostic tests themselves are medical procedures or tools employed to either confirm or rule out a particular condition or disease. The rising demand for quick, accurate results in healthcare settings is driving the increasing prevalence of rapid diagnostic tests (RDTs). Specifically, rapid influenza diagnostic tests (RIDTs) have the capability to detect influenza viral antigens in 10-15 minutes, with a moderate sensitivity range of 50-70%. As an example, in July 2024, data from the Australian Institute of Health and Welfare, a Australia-based government agency that provides information on health and diseases, showed an increase in the volume of diagnostic imaging services from 28.4 million in 2021–22 to 29.7 million in 2022–23. Thus, rapid diagnostic tests are clearly fueling the growth of the influenza diagnostic market.

Which Key Segments Fueling The Influenza Diagnostic Market?

The influenza diagnosticmarket covered in this report is segmented –

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Subsegments:

1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)

2) By Viral Culture: Cell Culture; Egg-based Culture

3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay

5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

What Trends Are Expected To Drive The Influenza Diagnostic Market?

Companies operating in the influenza diagnostic market are actively developing innovative products, such as the Lucira COVID-19 & Flu Home Test, for the simultaneous rapid qualitative detection of multiple viruses. The Lucira COVID-19 and Flu Home Test functions as a single-use, at-home kit that provides results from self-collected nasal swab samples in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US-based pharmaceutical company, obtained approval for the Lucira COVID-19 & Flu Home Test. This diagnostic tool is designed to identify influenza A and B, commonly known as the flu, as well as SARS-CoV-2, the virus responsible for COVID-19.

Which Major Industry Participants Are Leading The Influenza Diagnostic Market Growth?

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Influenza Diagnostic Market?

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Influenza Diagnostic Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2025, By The Business Research Company

Immunofluorescence Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795